Literature DB >> 25399625

A review of nicotinamide: treatment of skin diseases and potential side effects.

Heidi M Rolfe1.   

Abstract

Nicotinamide, also known as niacinamide, is the amide form of vitamin B3. It is a precursor of essential coenzymes for numerous reactions in the body including adenosine triphosphate (ATP) production. Nicotinic acid, also known as niacin, is converted into nicotinamide in the body. The use of topical nicotinamide in the treatment of acne vulgaris; melasma; atopic dermatitis; rosacea; and oral nicotinamide in preventing nonmelanoma skin cancer is discussed. The possible side effects and consequences of excessive nicotinamide exposure are reviewed, including suggestions nicotinamide might have a role in the development of diabetes, Parkinson's disease, and liver damage.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  acne vulgaris; dermatitis; melasma; niacinamide; nicotinamide; rosacea; skin cancer; vitamin B3

Mesh:

Substances:

Year:  2014        PMID: 25399625     DOI: 10.1111/jocd.12119

Source DB:  PubMed          Journal:  J Cosmet Dermatol        ISSN: 1473-2130            Impact factor:   2.696


  25 in total

1.  Niacin intake and risk of skin cancer in US women and men.

Authors:  Sang Min Park; Tricia Li; Shaowei Wu; Wen-Qing Li; Martin Weinstock; Abrar A Qureshi; Eunyoung Cho
Journal:  Int J Cancer       Date:  2017-02-14       Impact factor: 7.396

Review 2.  Therapeutic Potential of NAD-Boosting Molecules: The In Vivo Evidence.

Authors:  Luis Rajman; Karolina Chwalek; David A Sinclair
Journal:  Cell Metab       Date:  2018-03-06       Impact factor: 27.287

3.  Validation of diffuse correlation spectroscopy sensitivity to nicotinamide-induced blood flow elevation in the murine hindlimb using the fluorescent microsphere technique.

Authors:  Ashley R Proctor; Gabriel A Ramirez; Songfeng Han; Ziping Liu; Tracy M Bubel; Regine Choe
Journal:  J Biomed Opt       Date:  2018-03       Impact factor: 3.170

4.  Use of nicotinamide decorated polymeric cryogels as heavy metal sweeper.

Authors:  Elif Bilgin; Kadir Erol; Kazım Köse; Dursun A Köse
Journal:  Environ Sci Pollut Res Int       Date:  2018-07-28       Impact factor: 4.223

Review 5.  Natural Bioactive Compounds Targeting Epigenetic Pathways in Cancer: A Review on Alkaloids, Terpenoids, Quinones, and Isothiocyanates.

Authors:  Nasreddine El Omari; Saad Bakrim; Mohamed Bakha; José M Lorenzo; Maksim Rebezov; Mohammad Ali Shariati; Sara Aboulaghras; Abdelaali Balahbib; Mars Khayrullin; Abdelhakim Bouyahya
Journal:  Nutrients       Date:  2021-10-22       Impact factor: 5.717

Review 6.  Topical Treatments for Melasma and Their Mechanism of Action.

Authors:  Valeria González-Molina; Alicia Martí-Pineda; Noelani González
Journal:  J Clin Aesthet Dermatol       Date:  2022-05

Review 7.  Oral nicotinamide for non-melanoma skin cancers: A review.

Authors:  Samantha Vicki Hunt; Aaron Jamison; Raman Malhotra
Journal:  Eye (Lond)       Date:  2022-03-28       Impact factor: 4.456

8.  NAD supplementation improves mitochondrial performance of cardiolipin mutants.

Authors:  Jiajia Ji; Deena Damschroder; Denise Bessert; Pablo Lazcano; Robert Wessells; Christian A Reynolds; Miriam L Greenberg
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2022-01-18       Impact factor: 4.698

9.  An open-label, investigator-initiated, single-center, prospective, pilot clinical study to evaluate the efficacy of a skin whitening serum applied twice daily combined with a spot-preventing SPF50+ sunscreen in healthy female subjects with melasma hyperpigmentation.

Authors:  Mariateresa Cantelli; Maria Ferrillo; Corinne Granger; Gabriella Fabbrocini
Journal:  J Cosmet Dermatol       Date:  2021-06-25       Impact factor: 2.189

10.  Niacinamide and undenatured type II collagen modulates the inflammatory response in rats with monoiodoacetate-induced osteoarthritis.

Authors:  Kazim Sahin; Osman Kucuk; Cemal Orhan; Mehmet Tuzcu; Ali Said Durmus; Ibrahim Hanifi Ozercan; Nurhan Sahin; Vijaya Juturu
Journal:  Sci Rep       Date:  2021-07-19       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.